| Autor: |
Vano-Galvan S; #TricoHRC Research Group, Hair Disorders Unit, Dermatology Department, Ramón y Cajal University Hospital, Instituto Ramon y Cajal de Investigación Sanitaria, University of Alcala, Madrid, Spain; Hair Disorders and Hair Transplantation Unit, Grupo Pedro Jaen Clinic, Madrid, Spain., Reygagne P; Centre de Santé Sabouraud, Hôpital Saint Louis, Paris, France., Melo DF; Department of Dermatology, State University of Rio de Janeiro - UERJ, Rio de Janeiro, Brazil., Barbosa V; Section of Dermatology, University of Chicago Medicine, Chicago., Wu WY; Department of Dermatology, Huashan Hospital Fudan University, Shanghai 200040, China., Moneib H; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Piraccini BM; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Medical and Surgical Sciences University of Bologna, Italy. |
| Abstrakt: |
Seborrheic Dermatitis of the scalp (SSD) is a chronic and relapsing inflammatory skin condition. Current SSD treatments mainly consist of topical applications of anti-fungals and anti-inflammatory agents. to review information about SSD and to provide dermatologists with practical recommendations for managing adult SSD. Material and methods: Between September and December 2023, an international group of experts in dermatology and hair and scalp disorders met to discuss published data about SD, SSD, dandruff, and management options. A total of 131 manuscripts available from PubMed were analysed, discussed and used for the present consensus. Each author was asked to complete a table listing currently used treatments to treat SSD according to the literature and to their own experience. The authors confirmed their use and regimen and commented on local treatment exceptions. They then agreed on prescription practices and proposed a general treatment approach. Currently, approved therapies to manage moderate and severe forms of SSD do not exist and there is a need for adapted and approved medications that treat efficiently and safely the disease. We propose a treatment algorithm that allows for the treatment of all severity grades of SSD. This algorithm may be completed with local treatment specifications. Despite the lack of approved therapies to manage moderate forms of SSD, a treatment algorithm is proposed and may help prescribers to manage SSD more efficiently. |
